Tibiotalocalcaneal fusion in Charcot ankle arthropathy: Technical and biological considerations

Abstract

Charcot neuroarthropathy is a progressive destructive arthropathy that most commonly affects the foot and ankle in the setting of peripheral neuropathy, particularly diabetic neuropathy. The disease is characterized by inflammation, osseous resorption, instability, deformity, ulceration, and an elevated risk of amputation if not diagnosed and treated early. Management is stage dependent and requires a combination of offloading, immobilization, metabolic optimization, orthotic support, and, in selected cases, surgery. While acute disease is treated primarily nonoperatively, chronic deformity and instability frequently necessitate reconstruction to achieve a stable, plantigrade, ulcer-free foot. Among reconstructive options, tibiotalocalcaneal fusion remains one of the most important procedures for severe hindfoot and ankle involvement. It offers a limb-salvage solution in patients with fixed deformity, recurrent ulceration, or failed conservative treatment. However, the procedure remains challenging because of poor bone quality, neuropathic overload, impaired healing, and high complication rates. Modern strategies emphasize the use of superconstruct principles, rigid fixation, biologic augmentation, and strict postoperative protection to improve union and functional outcome. This article discusses the current management of Charcot neuroarthropathy across the disease spectrum, with particular focus on the indications, techniques, outcomes, and complications of tibiotalocalcaneal fusion.

Key Words: Charcot neuroarthropathy; Tibiotalocalcaneal fusion; Diabetic foot; Hindfoot reconstruction; Offloading; Arthrodesis; Intramedullary nail; Superconstruct

Core Tip: Charcot neuroarthropathy requires early diagnosis, strict offloading, and stage-specific treatment. Most acute cases are managed conservatively, but advanced hindfoot and ankle deformity often require tibiotalocalcaneal fusion. Success depends on rigid fixation, biological support, and careful postoperative protection.

INTRODUCTION

Charcot neuroarthropathy (CN) also termed Charcot neuropathic osteoarthropathy is a progressive, non-infectious destructive arthropathy of the bones, joints, and soft tissues of the foot and ankle occurring in the setting of peripheral neuropathy[1,2]. Diabetic peripheral neuropathy accounts for more than 80% of all CN encountered in contemporary practice, and the condition carries disproportionate morbidity compared with other diabetic foot complications because of its potential to produce severe skeletal deformity, chronic ulceration, and ultimately limb loss[3,4].

The ankle and hindfoot are involved in approximately 10%-20% of all CN cases. Although less common than midfoot involvement, hindfoot and ankle CN carries the greatest functional impact because it disrupts the fundamental load-bearing axis of the lower extremity and creates multi-planar deformity that cannot be accommodated by standard orthotic devices. The natural history of untreated or inadequately managed ankle CN is progressive collapse into valgus or varus deformity, recurrent ulceration over bony prominences, deep infection, and even below-knee amputation, which itself carries a five-year mortality exceeding 50% in diabetic patients[4-6].

Surgical reconstruction of the destroyed Charcot ankle aims to achieve a stable, plantigrade, braceable foot that permits functional ambulation, prevents recurrent ulceration, and preserves the limb. Tibiotalocalcaneal (TTC) fusion has emerged as the cornerstone procedure for this reconstruction, spanning both the tibiotalar and subtalar joints to create a single stable hindfoot unit[7,8]. However, achieving reliable fusion in the biological environment of Charcot bone remains one of the most challenging problems in foot and ankle surgery, with nonunion rates consistently reported at 15%-40% across large series far exceeding those in non-neuropathic patients undergoing the same procedure[8-10].

The reasons for this high failure rate are deeply rooted in the pathobiology of CN: Compromised vascularity, dysregulated receptor activator of nuclear factor kappa B ligand/osteoprotegerin signaling, impaired mesenchymal stem cell function, advanced glycation end-product accumulation, and the mechanical consequences of repetitive unperceived loading in an insensate limb all conspire to create a hostile environment for bone healing[11-13]. Recognition of this multifactorial biological impairment has driven a paradigm shift from purely mechanical fixation strategies toward combined approaches that simultaneously address mechanical stability and biological deficiency[11,14].

This opinion review discusses the management of CN in general while focusing on TTC fusion as the key reconstructive option for advanced hindfoot and ankle involvement. The objective is to provide a practical and evidence-informed narrative that bridges conservative care and complex surgical reconstruction.

PATHOPHYSIOLOGY OF CHARCOT BONE

Molecular mechanisms

The pathogenesis of CN remains multifactorial. The classic neurotraumatic theory proposes that loss of protective sensation allows repetitive unrecognized microtrauma to continue, while the neurovascular theory emphasizes autonomic dysregulation, hyperemia, and osteolysis. Contemporary understanding integrates both mechanisms and highlights inflammatory upregulation, excessive osteoclastic activity, and altered bone remodeling as central drivers of progression[15,16].

Classification

The Eichenholtz classification remains clinically useful because it correlates with treatment strategy (Figure 1). Stage 0 reflects a prodromal inflammatory phase with normal or near-normal radiographs, stage I shows fragmentation and active destruction, stage II marks coalescence, and stage III represents reconstruction with residual deformity. Acute active disease is treated primarily with immobilization and offloading, while reconstruction is usually considered when the limb becomes stable enough biologically yet remains non-plantigrade, unstable, or ulcer-prone[17].

Figure 1 Eichenholtz staging and Sanders-Frykberg classification of Charcot neuroarthropathy. A: Stage I - acute development phase: Periarticular fragmentation, joint dislocation, periarticular edema, warmth, and erythema; B: Stage II - coalescence phase: Consolidation of debris, early periosteal new bone formation, subsiding acute inflammation; C: Stage III - reconstruction phase: Established sclerosis, fixed deformity, remodeling of fusion mass.

Anatomic patterns also matter. Charcot involvement of the ankle and hindfoot, corresponding broadly to Sanders-Frykberg type IV and V patterns, creates multiplanar malalignment and threatens limb salvage more directly than many midfoot patterns. This is the subgroup in which TTC fusion is most relevant[15,18].

CONSERVATIVE MANAGEMENT

The management of active CN begins with immediate offloading. The International Working Group on the Diabetic Foot guideline recommends non-removable knee-high immobilization as first-line treatment, with total contact casting remaining the most established option for active disease (Table 1)[5]. Non-weight-bearing or very restricted protected loading is generally used during the acute inflammatory phase, especially when deformity progression is a concern[5].

Table 1 Stage-based management of Charcot neuroarthropathy.

Stage	Clinical features	Main treatment
Stage 0	Warmth, swelling, subtle imaging changes	Immediate immobilization and offloading
Stage I	Fragmentation, active destruction	Non-removable knee-high offloading, close monitoring
Stage II	Coalescence	Protected progression, orthotic planning
Stage III	Consolidated deformity	Custom bracing or reconstruction if non-plantigrade/unstable

Clinical monitoring relies on reduction in swelling, erythema, and temperature difference, supported by serial imaging when needed. After remission, transition to a Charcot restraint orthotic walker, custom brace, or therapeutic footwear is required to protect the limb and prevent recurrence[19,20]. Conservative treatment is effective in many patients, particularly when diagnosis is early, but it cannot reliably correct established severe hindfoot or ankle malalignment.

Adjunctive pharmacologic therapies such as bisphosphonates or other antiresorptive agents have been studied, but evidence remains inconsistent and they are not substitutes for mechanical offloading. Multidisciplinary optimization remains essential, including glycemic control, vascular assessment, ulcer prevention, nutritional support, smoking cessation, and infection exclusion[21-23].

Goals of surgical reconstruction

The primary surgical goals in Charcot ankle arthropathy are: (1) Achievement of a stable, plantigrade foot; (2) Limb salvage by preventing recurrent ulceration and deep infection; (3) Restoration of functional ambulation; and (4) Reduction of the risk of below-knee amputation. These goals are achieved through TTC fusion, which eliminates the destroyed and unstable tibiotalar and subtalar joints and creates a single rigid tibio-calcaneal unit[24,25].

Indications

TTC fusion is indicated in[26]: (1) Eichenholtz stage II or III disease with established hindfoot collapse, fixed valgus or varus deformity, or tibiotalar/subtalar instability; (2) Failed conservative management (minimum 3-6 months TCC) with progressive deformity or unacceptable functional limitation; (3) Recurrent or chronic ulceration attributable to bony prominences that cannot be managed conservatively; (4) Impending skin breakdown over deformed bony prominences with risk of deep infection; and (5) Sanders-Frykberg Pattern IV or V involvement with loss of hindfoot structural integrity.

Contraindications

Absolute contraindications include[8,27]: (1) Active deep infection or osteomyelitis - requires staged eradication before fusion; (2) Eichenholtz stage I active inflammatory phase - surgical intervention should be deferred; (3) Severe peripheral vascular disease with ankle-brachial index below 0.5 or non-reconstructable ischemia; and (4) Non-reconstructable soft-tissue deficiency over the planned surgical approach.

Relative contraindications requiring individualized assessment

(1) Uncontrolled diabetes (HbA1c > 10%) - metabolic optimization should be attempted preoperatively; (2) Severe osteoporosis with inadequate cortical purchase for fixation; (3) Active Charcot flare with significant periarticular edema and erythema; and (4) Patient non-compliance risk with postoperative offloading protocol.

Preoperative assessment before TTC fusion

Successful TTC fusion starts with careful preoperative selection: Vascular status must be documented, wounds and infection must be assessed, and the disease should be characterized as inactive or quiescent because reconstruction during active Charcot has been associated with less favorable outcomes in several series. Glycemic control, renal function, body mass index, smoking status, and the presence of peripheral vascular disease or end-stage renal disease all influence risk and should be optimized before surgery whenever possible[28,29].

Imaging should include standing radiographs if tolerated, with computed tomography often useful to define bone loss, talar collapse, subtalar destruction, and fusion planning. Magnetic resonance imaging may help when osteomyelitis or active disease remains uncertain. Soft tissue quality, ulcer location, and previous incisions must also shape the surgical approach[30,31].

Patient counseling is critical: The patient must understand that TTC fusion in Charcot disease carries higher risks than routine hindfoot fusion, often requires prolonged non-weight-bearing or protected weight-bearing, may need bracing even after union, and can still end in revision or amputation if infection or nonunion develops[10,32].

TTC fusion as a reconstructive strategy

The philosophy of TTC fusion in Charcot disease differs from standard arthrodesis. Because neuropathic bone is weak and the surrounding mechanical environment is hostile, the procedure must account for bone loss, deformity, biologic deficiency, and the risk of recurrent overload. This is why many surgeons apply superconstruct principles, extending fixation beyond the zone of injury, resecting enough bone to achieve deformity correction without soft-tissue tension, using the strongest tolerated implants, and maximizing the mechanical advantage of the construct[33,34].

Fixation methods

Retrograde intramedullary nailing: Retrograde intramedullary nail (RIMN) fixation is the most widely adopted technique for TTC fusion because of its favorable biomechanical profile, minimal soft-tissue disruption, and load-sharing rather than load-bearing design (Table 2). The nail is introduced through a calcaneal plantar portal and spans both the subtalar and tibiotalar joints, with cross-locking screws providing rotational and length stability. Modern nail designs incorporate anterior angulation matching normal tibial alignment, integrated compression mechanisms for dynamic axial loading, and increased diameter options suited to Charcot bone[35,36].

Table 2 Main fixation options for tibiotalocalcaneal fusion in Charcot hindfoot and ankle disease.

Method	Advantages	Limitations
Retrograde intramedullary nail	Load sharing, spans ankle and subtalar joints, limited stripping	Implant failure, nonunion, infection
Plate fixation	Alignment control, useful when nailing unsuitable	Wider exposure, soft-tissue risk
External fixation	Useful in infection or poor soft tissue	Pin-related problems, patient burden
Hybrid fixation	Added stability in selected salvage cases	Complexity and limited evidence

Functional outcome studies suggest that hindfoot nailing can improve ambulatory capacity and patient-reported function, but union times and complication rates remain variable. A recent review also noted that larger nail diameter and supplementary compression strategies may improve union in TTC arthrodesis[37].

Plate fixation: Plating remains an alternative when intramedullary nailing is unsuitable because of anatomy, prior surgery, severe deformity, or surgeon preference. Medial locking plate constructs - including blade plates, anatomical locking plates, and combined anterolateral/posteromedial dual plating - provide excellent deformity correction capability and broad surface area for bone-implant contact[38]. Locking plate technology has improved the rigidity of plate constructs in osteopenic Charcot bone by engaging cortical threads with locked screws that resist pullout independently of bone quality. However, plates require more extensive soft-tissue dissection than RIMN, are associated with higher wound complication rates in the neuropathic foot and may be prone to hardware failure under high cyclic loading if union is delayed[8,27].

External fixation: External fixation, particularly circular frames, still has an important role when infection, ulceration, poor soft tissues, or massive deformity make internal fixation risky. It permits gradual correction and can avoid internal hardware in contaminated fields. However, external fixation is demanding for both surgeon and patient, and pin-related complications are frequent[39,40].

Hybrid constructs

In selected high-risk cases, combined internal and external fixation may be used to augment stability or protect a tenuous internal construct. The systematic review of Charcot reconstruction outcomes found that combined fixation represented a small proportion of reported cases, reflecting its role as a specialized salvage option rather than a standard solution[38].

The superconstruct philosophy

The superconstruct concept, as articulated by Sammarco[33], represents the current philosophical framework for surgical reconstruction in severe CN deformity. A superconstruct is defined by four principles: (1) Fusion extends beyond the zone of injury to include joints not typically fused in standard reconstruction; (2) Bone resection is performed to reduce deformity and reduce soft-tissue tension rather than attempting correction by distraction; (3) The strongest device that can be safely implanted is used; and (4) The device is applied in the most biomechanically advantageous position regardless of standard anatomical placement guidelines.

In the context of TTC fusion for CN, the superconstruct philosophy means extending the nail proximally into the tibial diaphysis for greater cortical purchase, using maximum diameter nails, incorporating additional locking options, and considering supplementary fibular plating or tibiofibular syndesmotic screws to distribute stress across a broader construct.

SURGICAL APPROACHES

Transfibular approach

The traditional transfibular approach involves excision of the distal fibula to provide joint visualization and a source of local autograft bone. Fibular excision provides excellent exposure of both the tibiotalar and subtalar joints, simplifies joint preparation, and yields a volume of local bone graft. However, it sacrifices the lateral structural buttress of the ankle, eliminates the tibiofibular syndesmosis as an additional fusion surface, and may destabilize the construct by removing the periosteal sleeve and lateral bony wall that normally constrain the ankle[41,42].

Fibular preservation techniques

Fibular-preserving approaches have been developed to maintain the distal fibula as a structural element through controlled osteotomy while still allowing adequate joint visualization. The transmalleolar trap-door osteotomy - a controlled lateral malleolar osteotomy performed 2-4 cm proximal to the ankle joint line with meticulous preservation of periosteal soft-tissue attachments - allows the fibula to be mobilized in a hinged manner to expose the fusion surfaces without circumferential stripping. After joint preparation and graft insertion, the fibula is reduced and fixed, contributing to the lateral wall of the fusion construct and creating a contained chamber for graft material[43].

Fetter and DeOrio[44] described a posterior approach with fibular preservation for TTC arthrodesis in CN and reported comparable fusion rates to the transfibular technique with the potential advantage of preserved lateral structural integrity.

Posterior approach

The posterior approach to TTC fusion provides direct access to both the posterior tibiotalar and subtalar joints through a single incision, with minimal disruption of the lateral ankle anatomy. It is particularly advantageous in cases with significant hindfoot valgus deformity, where the posterior approach allows direct correction of the deformity vector. The posterior approach requires meticulous protection of the sural nerve, peroneal tendons, and posterior tibial neurovascular bundle, and is associated with lower wound complication rates than the transfibular approach in patients with compromised lateral ankle soft tissues[44,45].

Biologic augmentation

Charcot bone heals in a biologically impaired environment. For this reason, biologic augmentation has become increasingly attractive in TTC fusion. Options include autograft, allograft, demineralized matrix, structural grafts, bone marrow aspirate concentrate, platelet-rich preparations, and growth-factor-based materials[11,14].

The theoretical rationale is strong: Improved osteoconduction, osteoinduction, and in some cases osteogenesis may help counter delayed union and nonunion in neuropathic bone. However, the evidence remains heterogeneous and largely based on case series, technical reports, or mixed reconstruction cohorts. Biologic augmentation should therefore be viewed as a useful adjunct rather than a guaranteed solution[11,14].

Outcomes of TTC fusion in Charcot disease

Across the Charcot reconstruction literature, limb salvage is frequently achievable, but complication rates remain high. The systematic review by Ha et al[46] included 1116 reconstructed feet and reported an overall bone fusion rate of 86.1%, a complication rate of 36%, an amputation rate of 5.5%, and return to ambulation in 91% of patients, albeit with major heterogeneity and strong selection bias. These numbers support reconstruction as a valid option in specialized centers but also highlight the difficulty of the pathology.

For TTC-specific series, reported outcomes vary according to fixation method, infection burden, deformity severity, and disease activity. Functional outcome studies using hindfoot nails generally show improved function and acceptable fusion time, but persistent risks include infection, malalignment, nonunion, and implant failure. A recent study of TTC arthrodesis in hindfoot CN found no clear difference in outcome between milder and more severe preoperative deformity groups, but preoperative infected wounds and postoperative infection were associated with poor outcomes including below-knee amputation[47].

Deformity severity alone may not be the most important predictor of failure; biological and soft-tissue factors may be more decisive. That observation is clinically useful because it supports limb-salvage attempts even in severe deformity when soft-tissue and infection variables are favorable[47].

Risk factors for nonunion and failure

Nonunion remains one of the most feared complications after TTC fusion. Recent studies have emphasized that failure is rarely due to a single factor and usually reflects the interaction of host biology, disease severity, mechanical environment, and postoperative behavior. In Charcot populations, factors repeatedly associated with worse outcomes include peripheral vascular disease, infection, renal failure, obesity, poor glycemic control, active disease at the time of reconstruction, and poor compliance with postoperative protection[48].

The general TTC nonunion literature also points to smoking, diabetes, previous fusion failure, and compromised bone stock as important risks. Because Charcot patients often accumulate several of these factors, surgeons should expect a narrower margin for technical error than in routine hindfoot fusion[27].

Infection and ulcer-related considerations

Infection has a disproportionate effect on outcome in Charcot reconstruction. Even when an ulcer is clinically improved before surgery, a history of preoperative wound problems may signal a higher-risk limb. Deep infection can destabilize implants, compromise soft tissues, and convert a limb-salvage pathway into an amputation pathway[49].

When infection is present or strongly suspected, staged management may be preferable. This can include debridement, antibiotics, temporary stabilization, and delayed definitive fusion once infection is controlled. In some cases, external fixation or hybrid strategies may be safer than immediate internal fixation[50].

Postoperative management

The postoperative phase is central to success. Most TTC fusion constructs in Charcot patients require prolonged protection, typically with initial non-weight-bearing followed by gradual transition to protected weight-bearing only after clinical and radiographic evidence of stability emerges. Because neuropathic patients do not self-limit based on pain, failure of compliance can lead to early implant fatigue or loss of correction[47].

Long-term orthotic support is often necessary even after successful union. The goal is not merely fusion on radiographs, but preservation of a functional, ulcer-free, braceable limb over time. Follow-up should therefore include surveillance for recurrence, transfer ulceration, hardware-related symptoms, and contralateral Charcot changes[46].

Authors’ perspective

TTC fusion should not be viewed as a last desperate procedure performed only after collapse becomes catastrophic. In selected patients, it is a rational limb-salvage strategy that can prevent recurrent ulceration, improve ambulatory function, and avoid early amputation. At the same time, it should not be offered casually. The operation belongs in a broader program of Charcot management that includes offloading, metabolic optimization, infection control, soft-tissue judgment, and realistic counseling[51,52].

From a practical standpoint, three principles deserve emphasis. First, timing matters: Reconstruction during uncontrolled active disease or unresolved infection is more likely to fail. Second, construct design matters: Surgeons should favor fixation strategies that respect superconstruct principles and the weak biology of Charcot bone. Third, postoperative protection matters as much as intraoperative technique, because even a well-executed fusion can fail under premature loading[53].

Future directions

The literature remains limited by retrospective designs, heterogeneous definitions of union, variable follow-up, and selection bias toward specialized centers. Future work should focus on prospective multicenter registries, disease-specific functional outcome tools, comparative studies of fixation methods, and better stratification of infection and vascular risk. There is also a need for more rigorous evaluation of biologic augmentation and of staged strategies in infected or previously ulcerated limbs.

As the evidence base grows, the field may move toward a more personalized reconstruction algorithm that incorporates disease activity, deformity pattern, bone loss, soft-tissue status, and systemic risk factors. Until then, surgeon judgment and multidisciplinary coordination remain decisive.

CONCLUSION

CN remains a limb-threatening disorder that demands early recognition and stage-based treatment. Conservative management is fundamental in active disease, but severe hindfoot and ankle involvement often requires reconstruction to restore a stable plantigrade limb. TTC fusion has become a central reconstructive strategy for this purpose. No single fixation method has demonstrated superiority in controlled trials; RIMN remains the most widely adopted first-line construct because of its favorable biomechanical profile and lower wound complication rate compared with plate fixation. Biological augmentation represents an evidence-aligned adjunct that partially compensates for the osteogenic deficit of Charcot bone without significant additional morbidity. Postoperative non-weight-bearing compliance is the single most modifiable determinant of union and must be enforced through non-removable immobilization strategies.